BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. SNCA, cell-cell adhesion, Pseudomonas infection, Stem cell, Personalized medicine)
Bookmark Forward

QuickView for CDK2 (gene)


Body Atlas

Most Correlated Tissues

  1. Placenta
  2. Thymus gland
  3. Plasma cell of spleen
  4. Superior cervical ganglion
  5. Granulocyte-macrophage progenitor cell of bone marrow
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Toxic nephropathy
  2. Tularemia
  3. Infection due to Mycobacterium tuberculosis
  4. Disorder of pregnancy
  5. Zika virus disease
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. 4-hydroxyestradiol-17 beta
  2. arenobufagin
  3. cinobufotalin
  4. Antipyrine
  5. bufogenin
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. hsa-miR-34a-5p
  2. TDP2
  3. DUSP5
  4. CDK2
  5. SIRT6
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Discovery of novel macrocyclic derivatives as potent and selective cyclin-dependent kinase 2 inhibit…
  2. Exploring the mechanism of action of spirooxindoles as a class of CDK2 inhibitors: a structure-based…
  3. Clinicopathological Significance of Cyclin-Dependent Kinase 2 (CDK2) in Ductal Carcinoma In Situ and…
  4. Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation - …
  5. CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer …
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. (VELA) Study of BLU-222 in Advanced Solid Tumors
  2. PF-07104091 as a Single Agent and in Combination Therapy
  3. Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With M…
  4. A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001…
  5. Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With …
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.